As being a partial agonist, YK11 only partially activates androgen receptors and may contend instantly with endogenous Testosterone and DHT for receptor activation.We know this isn’t an precise facet impact, but it is a BIG con that you need to be familiar with. Why? Mainly because all of its claims are depending on mobile experiments. There's no